![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, April 11, 2016 10:48:45 AM
Stock price climbing steadily. within 1 tick of highest run rate (not spike induced) price for 18 months.
Market is saying company is in sound financial shape
Desperate-times-indeed
o Mounting legal fees [Possibly but had high fees for last few years due to FDA processes]
o FDA Clearance no where in site [FDA run rate indicates decision for BIEL application due this month based on public data on applications being currently cleared]
o Every item sold results in additional losses [FALSE profit before overheads was at record 80-90% last quarter for each sold they make a lot of money. overheads are what needs to be controlled - FDA and SEC don't help here]
o SEC facilitating an end to the family loans [Not true actually - so long as registered they can sell shares legally to anyone but I guess they wont as they don't need any more cash]
o AS likely above 20B [why no dilution for 4 - 6 months current IBEX loan unlikely to be converted any time soon.]
o OS growing, Toxic dilution continues at accelerated pace [No dilution for 4-6 months]
Alliance Creative Group (ACGX) Releases Q2 2024 Financial and Disclosure Report with an increase of over $130,000 in Net Income from Q2 2023 to Q2 2024 • ACGX • Aug 14, 2024 8:30 AM
Avant Technologies Unveils AI-Powered Healthcare Infrastructure to Deliver Intelligent Healthcare Solutions • AVAI • Aug 14, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q2 FY2024 Financial Results • SNWV • Aug 13, 2024 7:11 AM
Kona Gold Beverages, Inc. Nears Completion of Reverse Merger with New Candidate • KGKG • Aug 12, 2024 10:00 AM
Maybacks Global Entertainment and DigiTrax Entertainment Sign Agreement to Broadcast "Karaoke Cloud" on iDreamCTV • AHRO • Aug 12, 2024 8:45 AM
HealthLynked Partners with RxSpark to Enhance Medication Access and Management for Patients • HLYK • Aug 12, 2024 8:00 AM